143 related articles for article (PubMed ID: 8980909)
41. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models.
Kobayashi H; Shinohara H; Fujie M; Gotoh J; Itoh M; Takeuchi K; Terao T
Int J Cancer; 1995 Nov; 63(3):455-62. PubMed ID: 7591248
[TBL] [Abstract][Full Text] [Related]
43. Suppressive effects on cell proliferation and motility in gastric cancer SGC-7901 cells by introducing ulinastatin in vitro.
Wang J; Chen X; Su L; Zhu Z; Wu W; Zhou Y
Anticancer Drugs; 2016 Aug; 27(7):651-9. PubMed ID: 27187019
[TBL] [Abstract][Full Text] [Related]
44. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors.
Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F
Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase.
Suzuki M; Kobayashi H; Kanayama N; Saga Y; Suzuki M; Lin CY; Dickson RB; Terao T
J Biol Chem; 2004 Apr; 279(15):14899-908. PubMed ID: 14747469
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.
Towle MJ; Lee A; Maduakor EC; Schwartz CE; Bridges AJ; Littlefield BA
Cancer Res; 1993 Jun; 53(11):2553-9. PubMed ID: 8495419
[TBL] [Abstract][Full Text] [Related]
47. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
48. Amiloride and urinary trypsin inhibitor inhibit urothelial cancer invasion.
Oka N; Okumura Y; Kanayama HO; Izaki H; Okamoto M; Kido H; Kagawa S
Eur Urol; 2003 Dec; 44(6):737-41. PubMed ID: 14644129
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury.
Nakatani K; Takeshita S; Tsujimoto H; Kawamura Y; Sekine I
J Leukoc Biol; 2001 Feb; 69(2):241-7. PubMed ID: 11272274
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator expression in RC-K8 human lymphoma cells.
Nomura N; Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Higashiyama K; Fujimaki M; Sakuragawa N
Thromb Haemost; 1996 Jun; 75(6):928-32. PubMed ID: 8822588
[TBL] [Abstract][Full Text] [Related]
51. Role of protein kinase C in the regulation of prostaglandin synthesis in human endothelium.
Garcia JG; Stasek J; Natarajan V; Patterson CE; Dominguez J
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):315-25. PubMed ID: 1540395
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
[TBL] [Abstract][Full Text] [Related]
53. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
54. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.
Kobayashi H; Shinohara H; Ohi H; Sugimura M; Terao T; Fujie M
Clin Exp Metastasis; 1994 Mar; 12(2):117-28. PubMed ID: 8306525
[TBL] [Abstract][Full Text] [Related]
55. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity.
Zucali JR; Morse C; Dinarello CA
Exp Hematol; 1990 Sep; 18(8):888-92. PubMed ID: 2167234
[TBL] [Abstract][Full Text] [Related]
56. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.
Takahashi K; Uwabe Y; Sawasaki Y; Kiguchi T; Nakamura H; Kashiwabara K; Yagyu H; Matsuoka T
Am J Physiol; 1998 Jul; 275(1):L47-54. PubMed ID: 9688934
[TBL] [Abstract][Full Text] [Related]
57. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
Ziegler A; Hagmann J; Kiefer B; Nagamine Y
J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176
[TBL] [Abstract][Full Text] [Related]
58. Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells.
Aguirre Ghiso JA; Farías EF; Alonso DF; Bal de Kier Joffé E
Int J Cancer; 1998 May; 76(3):362-7. PubMed ID: 9579573
[TBL] [Abstract][Full Text] [Related]
59. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
van de Kar NC; Kooistra T; Vermeer M; Lesslauer W; Monnens LA; van Hinsbergh VW
Blood; 1995 Feb; 85(3):734-43. PubMed ID: 7530504
[TBL] [Abstract][Full Text] [Related]
60. Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.
Kobayashi H; Fujie M; Shinohara H; Ohi H; Sugimura M; Terao T
Int J Cancer; 1994 May; 57(3):378-84. PubMed ID: 8168999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
